Inviting comments on consideration of the proposal regarding Issue of use of brand name extensions by the pharmaceutical firms

CDSCO (India)

NOTICE

Published: 7/6/2026Detected: 7/6/2026

Seeks stakeholder input on a regulatory proposal governing when and how pharmaceutical firms may use brand name extensions.

Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.

#CDSCO

#brand name extensions

#pharmaceutical labeling

#product naming

#regulatory proposal

Access the original document directly from INDIA CDSCO.

Free plan, 2-minute setup, no credit card required.

Automated regulatory intelligence monitoring for pharmaceutical and biotech professionals. Track FDA, EMA, and Health Canada updates seamlessly.

Not affiliated with the FDA, EMA, or Health Canada.